bioMérieux Launches Rapid PCR Solution for Probiotic Species Verification

bioMérieux Launched PCR Testing Solution to Verify Probiotic Species in Dietary Supplements Manufacturing
With GENE-UP PROBIOTIC SPECIES ID, bioMérieux presents a first-of-its-kind commercialized species-level detection PCR1 services for in-house quality control teams and external laboratory collbration. This novel services verifies dietary supplement label rights in 90 minutes or less, supporting bypass the expenses, challenging, and delays of traditional workflows. The services is recently available in the United States. For obtainability in various countries, consumer are invited to contact their local bioMérieux illustrative.

The advancement of GENE-UP PROBIOTIC SPECIES ID was created in partnering with NOW, a natural products leader with more than 50 years of involvement in the category and a well-developed reputation for product testing superiority. Before reliant on third-party reference laboratories for multi-strain variety identification on integrated formulation, NOW collabrated with bioMérieux to develop a rapid, more capable verification services that reflects a shared commitment to systematic rigor, operational effectiveness, and customer trust.

“In the U.S., where the probiotics market continues to grow and consumer scrutiny continues to rise, GENE‑UP® PROBIOTIC SPECIES ID gives manufacturers the confidence to stand behind their products and deliver precise species identification that supports label integrity and protects brand reputation” said Miguel Villa, Senior Vice President, Industrial Applications, North America, bioMérieux.

Representing probiotic effectiveness needs consistent species-level identification, yet major presenting quality control strategies are expensive, complex, or slow placing working strain on quality teams and restraining routine testing. These compressions are increasing demand for rapid, more practical testing services which helps quality, transparency, and consistency deprived of compromising systematic robustness.

"Probiotic manufacturers are navigating a rapidly evolving landscape where ensuring reliable species verification is becoming essential, not only for quality control, but also for minimizing operational risk, supporting accurate label claims and maintaining market access in a highly competitive category.” explained Alejo Migones, Senior Vice President, Global Food Safety & Quality, bioMérieux.

GENE-UP PROBIOTIC SPECIES ID supports quality control teams meet the demands of this emergency landscape with precious identification of the 18 most generally applied probiotic species in the capsule and powder formats, involving Lactobacillus acidophilus, Lactobacillus rhamnosus, and Bifidobacterium lactis, in 90 minutes or less.

“Waiting weeks for compendial-based species identification created bottlenecks across our operations, from delayed production release to increased holding costs and unnecessary product risk. Our partnership with bioMérieux to develop GENE-UP® PROBIOTIC SPECIES ID gives us, as well as the industry at large, the ability to generate accurate, on-site species-level results in less than 90 minutes. That speed and accessibility not only help us hit production targets and minimize waste but also strengthen our ability to consistently deliver validated label claims to protect the integrity of our brand.” Said by Maria Mendres, Microbiology Manager, NOW

According to Towards Healthcare, the probiotics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 130.47 billion in 2026 to approximately USD 429.01 billion by 2035, representing a compound annual growth rate (CAGR) of 14.14% from 2026 to 2035, driven by probiotics supports to crowd out injurious bacteria, and supports to inhibit inflammation, increases immunity, and manufactures neurotransmitters, in many other functions. Probiotics increases the manufacturing of antimicrobial substances, such as short chain fatty acids and organic acids, and improves the activity of certain immune cells, all of which supports to defend against challenging microbes. Probiotics supports enhances the function and lowers the permeability of intestinal barrier, avoiding harmful pathogens from entering the blood circulation.

Furthermore producer, GENE‑UP PROBIOTIC SPECIES ID is being accepted by third-party reference laboratories seeking to extend their probiotic testing abilities. The assays offers a rapid and standardized strategy to species detection, providing as a complementary standard to sequencing for routine testing and high‑throughput screening. Intended for laboratory workflows, the services helps timely label verification, supports laboratories manage growing sample volumes, and enables sequencing resources to be reserved for challening analytical requirement.

This is the advancement diagnostic novalties from bioMérieux’s xPRO Program, allowing organization leaders to collabrate directly with bioMérieux experts to speed-up the advancement and commercialization of next-generation molecular diagnostics which solve pressing quality and safety complexities.

Furthermore species identification with GENE-UP PROBIOTIC SPECIES ID, bioMérieux offers game-changing diagnostics services such as detection, enumeration and environmental monitoring which supports dietary supplement producer meet their microbial quality testing complexities, while enhancing overall operations effectiveness and complying with guidelines.

About BioMérieux

A global leader in the sector of in vitro diagnostics for more than 60 years, bioMérieux offers diagnostic services such as systems, reagents, software which regulate the source of disease and contamination to enhance patient health and confirms consumer safety. bioMérieux offers a large set of diagnostic serves to diagnose and treating infections, and support physicians in the timely management and identification. The organization products are significantly used for diagnosing infectious diseases. They are used for identifying microorganisms in agri-food, healthcare, and cosmetic products. The organization products are significantly used for diagnosing infectious diseases. They are applied for detecting microorganisms in agri-food, biopharmaceutical, and cosmetic products. Fast and actionable diagnostics are significant in fighting significant challenges such as antibiotic resistance, sepsis, and food borne illness. 

A recent report by Towards Healthcare highlights that the probiotics market is growing because probiotics helps health in various ways, such as helping immune system function accurately, aiding in digestion or growing nutrient absorption. Furthermore, some probiotics supports lessen some digestive symptoms like antibiotic-associated diarrhea. Probiotics are known for their capability to supports optimize digestive process. It increases regularity, particularly for those who suffer from constipation. Probiotics are called for their capability to supports optimize digestive technology. It increases regularity, perticularly for those who suffer from constipation. Probiotics can also prevent vaginal yeast infections, urogenital infections, and bacterial vaginosis by keeping the vaginal microbiome in equilibrium. Probiotics e consumed through fermented supplements or foods.